CNS Drugs (CNS D)

CNS Drugs is a peer‑reviewed, international medical journal focusing on the drug therapy of neurological and psychiatric disorders. It publishes reviews, original research, clinical perspectives, and commentary that help clinicians, pharmacologists, and researchers understand current and emerging drug treatments for central nervous system (CNS) diseases. Coverage includes clinical pharmacology, efficacy and adverse effects of drugs for neurological conditions (e.g., epilepsy, multiple sclerosis, Parkinson’s disease) and psychiatric disorders (e.g., depression, anxiety, schizophrenia), as well as bench‑to‑bedside perspectives on new therapies and guidelines in clinical practice. The journal combines evidence‑based analysis with practical insights to support rational pharmacotherapy in neurology and psychiatry.CNS Drugs focuses on the pharmacological management of central nervous system disorders, bridging basic pharmacology with clinical application. Major topics include the therapeutic implications of neuroscience research on psychiatric and neurological drug therapies, comprehensive narrative reviews on clinical management, evaluations of drug efficacy and safety, and practical guidance on pharmacotherapy. It also highlights novel drug classes, emerging treatments, and therapeutic strategies to improve outcomes in CNS disease.

CNS Drugs (CNS D) is :-

• International, Peer-Reviewed, Open Access, Refereed, Pharmacology (medical), Psychiatry and Mental health, Clinical Neurology, Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement, Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry., Original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, pharmacoeconomic and pharmacoepidemiological studies , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1172-7047, E-ISSN: 1179-1934, Established: 1994, Impact Factor: 7.4
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE